tiprankstipranks
Trending News
More News >

10x Genomics price target lowered to $12 from $14 at UBS

UBS lowered the firm’s price target on 10x Genomics (TXG) to $12 from $14 and keeps a Neutral rating on the shares. The firm updated its forecast to reflect ongoing pressures in academic funding, the analyst tells investors in a research note.

Don’t Miss TipRanks’ Half Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1